Work

Phase IB dose escalation study of bortezomib and sunitinib in patients with refractory solid tumors.

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.2538

Authors: J. S. Kauh, R. D. Harvey, D. H. Lawson, T. K. Owonikoko, M. Tighiouart, S. S. Ramalingam, D. M. Shin, C. M. Lewis, B. F. El-Rayes, F. R. Khuri

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2529466255

Cites:

Cited by:

Related to: 10